Filter no-reflow during percutaneous coronary intervention of saphenous vein grafts: Incidence, predictors and effect of the type of protection device

EuroIntervention

Volumn 7, Issue 8, 2011, Pages 955-961

  Porto, Italo ^a   Belloni, Flavia ^a   Niccoli, Giampaolo ^a   Larosa, Claudio ^a   Leone, Antonio Maria ^a   Burzotta, Francesco ^a   Trani, Carlo ^a   De Maria, Giovanni Luigi ^a   Hamilton Craig, Christian ^b,c   Crea, Filippo ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Degeneration score; Filter no reflow; Saphenous vein graft; Troponin T

Indexed keywords

FIBRINOGEN RECEPTOR ANTAGONIST;

AGE; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD FILTER; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; FEMALE; HEART INFARCTION; HUMAN; INCIDENCE; MALE; MICROCIRCULATION; MULTIVARIATE ANALYSIS; NO REFLOW PHENOMENON; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PROTECTIVE EQUIPMENT; REFERENCE VALUE; SAPHENOUS VEIN GRAFT; SCORING SYSTEM; THERAPY EFFECT;

AGED; ANGIOGRAPHY; ANGIOPLASTY; EMBOLIC PROTECTION DEVICES; FEMALE; HUMANS; INCIDENCE; ITALY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NO-REFLOW PHENOMENON; RETROSPECTIVE STUDIES; SAPHENOUS VEIN; TROPONIN T;

EID: 84855390369     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV7I8A151     Document Type: Article

References (36)

1. Fitzgibbon GM, Kafka HP, Leach AJ, Keon WJ, Hooper GD, Burton JR. Coronary bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years. J Am Coll Cardiol. 1996;28:616-26. (Pubitemid 26288642)
2. Weintraub WS, Jones EL, Morris DC, King SB 3rd, Guyton RA, Craver JM. Outcome of reoperative coronary bypass surgery versus coronary angioplasty after previous bypass surgery. Circulation. 1997;95:868-77. (Pubitemid 27091527)
3. Salomon NW, Page US, Bigelow JC, Krause AH, Okies JE, Metzdorff MT. Reoperative coronary surgery. Comparative analysis of 6591 patients undergoing primary bypass and 508 patients undergoing reoperative coronary artery bypass. J Thorac Cardiovasc Surg. 1990;100:250-9; discussion 9-60.
4. de Feyter PJ, van Suylen RJ, de Jaegere PP, Topol EJ, Serruys PW. Balloon angioplasty for the treatment of lesions in saphenous vein bypass grafts. J Am Coll Cardiol. 1993;21:1539-49. (Pubitemid 23170424)
5. Platko WP, Hollman J, Whitlow PL, Franco I. Percutaneous transluminal angioplasty of saphenous vein graft stenosis: long-term follow-up. J Am Coll Cardiol. 1989;14:1645-50. (Pubitemid 20011853)
6. Selvanayagam JB, Porto I, Channon K, Petersen SE, Francis JM, Neubauer S, Banning AP. Troponin elevation after percutaneous coronary intervention directly represents the extent of irreversible myocardial injury: insights from cardiovascular magnetic resonance imaging. Circulation. 2005;111:1027-32. (Pubitemid 40354521)
7. Porto I, Selvanayagam JB, Van Gaal WJ, Prati F, Cheng A, Channon K, Neubauer S, Banning AP. Plaque volume and occurrence and location of periprocedural myocardial necrosis after percutaneous coronary intervention: insights from delayed-enhancement magnetic resonance imaging, thrombolysis in myocardial infarction myocardial perfusion grade analysis, and intravascular ultrasound. Circulation. 2006;114:662-9. (Pubitemid 44252308)
8. Ioannidis JP, Karvouni E, Katritsis DG. Mortality risk conferred by small elevations of creatine kinase-MB isoenzyme after percutaneous coronary intervention. J Am Coll Cardiol. 2003;42:1406-11. (Pubitemid 37267281)
9. Hong MK, Mehran R, Dangas G, Mintz GS, Lansky AJ, Pichard AD, Kent KM, Satler LF, Stone GW, Leon MB. Creatine kinase-MB enzyme elevation following successful saphenous vein graft intervention is associated with late mortality. Circulation. 1999;100: 2400-5.
10. Bryan AJ, Angelini GD. The biology of saphenous vein graft occlusion: etiology and strategies for prevention. Curr Opin Cardiol. 1994;9:641-9. (Pubitemid 24341152)
11. Webb JG, Carere RG, Virmani R, Baim D, Teirstein PS, Whitlow P, McQueen C, Kolodgie FD, Buller E, Dodek A, Mancini GB, Oesterle S. Retrieval and analysis of particulate debris after saphenous vein graft intervention. J Am Coll Cardiol. 1999;34: 468-75.
12. Keeley E, Velez C, O'Neill W. Long-term clinical outcome and predictors of major adverse events after percutaneous interventions on saphenous vein grafts. J Am Coll Cardiol. 2001;38:659-65. (Pubitemid 32835732)
13. Gaglia MA Jr, Torguson R, Xue Z, Gonzalez MA, Ben-Dor I, Suddath WO, Kent KM, Satler LF, Pichard AD, Waksman R.Outcomes of patients with acute myocardial infarction from a saphenous vein graft culprit undergoing percutaneous coronary intervention. Catheter Cardiovasc Interv. 2011;78:23-9.
14. Stone GW, Rogers C, Ramee S, White C, Kuntz RE, Popma JJ, George J, Almany S, Bailey S. Distal filter protection during saphenous vein graft stenting: technical and clinical correlates of efficacy. J Am Coll Cardiol. 2002;40:1882-8. (Pubitemid 35341970)
15. Bejarano J. Mechanical protection of cardiac microcirculation during percutaneous coronary intervention of saphenous vein grafts. Int J Cardiol. 2005;99:365-72. (Pubitemid 40363985)
16. Carter LI, Golzar JA, Cavendish JJ, Dixon SR. Embolic protection of saphenous vein graft percutaneous interventions. J Interv Cardiol. 2007;20:351-8. (Pubitemid 47429147)
17. Mauri L, Cox D, Hermiller J, Massaro J, Wahr J, Tay SW, Jonas M, Popma JJ, Pavliska J, Wahr D, Rogers C. The PROXIMAL trial: proximal protection during saphenous vein graft intervention using the Proxis Embolic Protection System: a randomized, prospective, multicenter clinical trial. J Am Coll Cardiol. 2007;50:1442-9. (Pubitemid 47494591)
18. Baim DS, Wahr D, George B, Leon MB, Greenberg J, Cutlip DE, Kaya U, Popma JJ, Ho KK, Kuntz RE. Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts. Circulation. 2002; 105:1285-90. (Pubitemid 34260417)
19. Halkin A, Masud AZ, Rogers C, Hermiller J, Feldman R, Hall P, Haber RH, Cambier PA, Caputo RP, Turco M, Kovach R, Brodie B, Herrmann HC, Kuntz RE, Popma JJ, Ramee S, Cox DA, Mehran R, Stone GW. Six-month outcomes after percutaneous intervention for lesions in aortocoronary saphenous vein grafts using distal protection devices: results from the FIRE trial. Am Heart J. 2006;151:915.e1-7.
20. Stone GW, Rogers C, Hermiller J, Feldman R, Hall P, Haber R, Masud A, Cambier P, Caputo RP, Turco M, Kovach R, Brodie B, Herrmann HC, Kuntz RE, Popma JJ, Ramee S, Cox DA. Randomized comparison of distal protection with a filter-based catheter and a balloon occlusion and aspiration system during percutaneous intervention of diseased saphenous vein aorto-coronary bypass grafts. Circulation. 2003;108:548-53. (Pubitemid 36961168)
21. Porto I, Choudhury RP, Pillay P, Burzotta F, Trani C, Niccoli G, Blackman DJ, Channon KM, Banning AP. Filter no reflow during percutaneous coronary interventions using the Filterwire distal protection device. Int J Cardiol. 2006;109:53-8.
22. Choudhury RP, Porto I, Banning AP. Images in cardiovascular medicine. Debris trapped by a distal protection device may mimic no-reflow during percutaneous coronary intervention. Circulation. 2004;109:803-4. (Pubitemid 38222903)
23. Thygesen K, Alpert JS, White HD. Universal definition of myocardial infarction. Eur Heart J. 2007;28:2525-38. (Pubitemid 47616190)
24. Garrone P, Biondi-Zoccai G, Salvetti I, Sina N, Sheiban I, Stella P, Agostoni P. Quantitative coronary angiography in the current era: principles and applications. J Interv Cardiol. 2009;22:527-36.
25. TIMI Study Group. The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. N Engl J Med. 1985;312: 932-6.
26. Gibson CM, Murphy SA, Rizzo MJ, Ryan KA, Marble SJ, McCabe CH, Cannon CP, Van de Werf F, Braunwald E. Relationship between TIMI frame count and clinical outcomes after thrombolytic administration. Thrombolysis In Myocardial Infarction (TIMI) Study Group. Circulation. 1999;99:1945-50. (Pubitemid 29183889)
27. Giugliano GR, Kuntz RE, Popma JJ, Cutlip DE, Baim DS. Determinants of 30-day adverse events following saphenous vein graft intervention with and without a distal occlusion embolic protection device. Am J Cardiol. 2005;95:173-7. (Pubitemid 40092080)
28. Naidu S, Turco M, Mauri L, Coolong A, Popma J, Kereiakes D. Contemporary incidence and predictors of major adverse cardiac events after saphenous vein graft intervention with embolic protection (an AMEthyst trial substudy). Am J Cardiol. 2010;105:1060-4.
29. Sdringola S, Assali A, Ghani M, Moustapha A. Risk assessment of slow or no-reflow phenomenon in aortocoronary vein graft percutaneous intervention. Catheter Cardiovasc Interv. 2001;54:318-24.
30. Prasad A, Rihal C, Lennon R, Singh M, Jaffe A, Holmes DJ. Significance of periprocedural myonecrosis on outcomes after percutaneous coronary intervention. An analysis of preintervention and postintervention troponin T levels in 5487 patients. Circ Cardiovasc Intervent. 2008;1:10-9.
31. Grube E, Schofer JJ, Webb J, Schuler G, Colombo A, Sievert H, Gerckens U, Stone GW. Evaluation of a balloon occlusion and aspiration system for protection from distal embolization during stenting in saphenous vein grafts. Am J Cardiol. 2002;89:941-5. (Pubitemid 34310291)
32. Bose D, Leineweber K, Konorza T, Zahn A, Brocker-Preuss M, Mann K, Haude M, Erbel R, Heusch G. Release of TNF-alpha during stent implantation into saphenous vein aortocoronary bypass grafts and its relation to plaque extrusion and restenosis. Am J Physiol Heart Circ Physiol. 2007;292:H2295-9. (Pubitemid 47084610)
33. Carrozza JP, Jr., Mumma M, Breall JA, Fernandez A, Heyman E, Metzger C. Randomized evaluation of the TriActiv balloon-protection flush and extraction system for the treatment of saphenous vein graft disease. J Am Coll Cardiol. 2005;46:1677-83. (Pubitemid 41531622)
34. Stone G, Rogers C, Hermiller J, Feldman R, Hall P, Haber R, Masud A, Cambier P, Caputo R, Turco M, Kovach R, Brodie B, Herrmann H, Kuntz R, Popma J, Ramee S, Cox D. Randomized comparison of distal protection with a filter-based catheter and a balloon occlusion and aspiration system during percutaneous intervention of diseased saphenous vein aorto-coronary bypass grafts. Circulation. 2003;108:548-53. (Pubitemid 36961168)
35. Jim M, Yiu K, Ko R, Ho H, Siu C, Chow W. Manual aspiration prior to stenting does not reduce the incidence of filter no reflow in saphenous vein graft lesions protected by FilterWire EX/EZ. Acute Card Care. 2010;12:92-5.
36. Coolong A, Baim DS, Kuntz RE, O'Malley AJ, Marulkar S, Cutlip DE, Popma JJ, Mauri L. Saphenous vein graft stenting and major adverse cardiac events: a predictive model derived from a pooled analysis of 3958 patients. Circulation. 2008;117:790-7. (Pubitemid 351640680)